x
Tell a Friend
 
Total
Ankle Replacement

Wright Medical Reaps FDA Approval for Augment

Wright Medical Reaps FDA Approval for Augment

Christopher DiGiovanni, M.D., the lead investigator for the product’s pivotal trial and chief of the Foot and Ankle Service in the Department of Orthopaedic Surgery at Massachusetts General Hospital, Harvard Medical School, said the FDA Approval, “provides a valuable new therapeutic healing option as an alternative to autograft in ankle and/or hindfoot fusion procedures, which is especially important since the outcomes of these interventions can at times be complicated by delayed union or non-union.”

Read more